News - Page 175 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Psychedelic Bulletin: atai IPOs on Nasdaq; Cybin to Target Anxiety Indications; Next Steps for California Decrim. Bill

Psychedelic Bulletin: atai IPOs on Nasdaq; Cybin to Target Anxiety Indications; Next Steps for California Decrim. Bill

Post published:June 18, 2021
Post category:Psychedelic Bulletin

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

Post published:June 18, 2021
Post category:Press Release

Read more about the article Diamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial

Diamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial

Post published:June 17, 2021
Post category:Press Release

Read more about the article Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics

Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics

Post published:June 17, 2021
Post category:Press Release

Read more about the article Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership

Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership

Post published:June 17, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences Corp. Announces Completion Of Reverse Takeover Transaction, Release From Escrow Of Private Placement Proceeds, And Final Approval For Listing On Neo Exchange

Awakn Life Sciences Corp. Announces Completion Of Reverse Takeover Transaction, Release From Escrow Of Private Placement Proceeds, And Final Approval For Listing On Neo Exchange

Post published:June 17, 2021
Post category:Press Release

Read more about the article Psyence Group Announces Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development

Psyence Group Announces Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development

Post published:June 17, 2021
Post category:Press Release

Read more about the article MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board

MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board

Post published:June 17, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET

Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET

Post published:June 17, 2021
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021

Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021

Post published:June 17, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.